Research to identify, optimize, and personalize early treatment for people affected by schizophrenia
Overview of Project
The RAISE Early Treatment Program (ETP) is a research study that will compare two different ways of providing treatment for people experiencing the early stages of schizophrenia and related illnesses. Both types of treatment emphasize a comprehensive initial evaluation at the earliest point after symptoms appear. ETP treatments might include medication, psychosocial therapies, and supportive services that address the multiple problems associated with these illnesses.
Dr. John Kane from the Feinstein Institute for Medical Research in Manhasset, NY is directing the ETP study. The study will take place in 34 community mental health centers and hospital outpatient mental health facilities in 21 states across the nation. For a complete list of the ETP treatment facilities see Study Locations. If you are interested in learning more about the study, please contact the ETP location nearest you.
If you are interested in accessing the RAISE ETP study manuals please see Study Manuals.
ETP is part of the National Institute of Mental Health's (NIMH)
Recovery After an Initial Schizophrenia Episode (RAISE) Project, under Contract No. HHSN-271-2009-00019C. It is one of two research teams
conducting the RAISE Project that are being supported in whole or in part with Federal funds from
the American Recovery and Reinvestment Act of 2009 and the NIMH, National Institutes of Health,
Department of Health and Human Services. For more information on activities of the NIMH RAISE project,
see www.nimh.nih.gov/RAISE.